Splice-site and missense mutations have been identified in tau associated w
ith frontotemporal dementia with parkinsonism linked to chromosome 17. In t
his study we assessed the genetic contribution of tau mutations to three pa
tient series with non-Alzheimer's (non-AD) degenerative dementia. The group
s included (1) a community-based dementia series from Minnesota, MN; (2) a
referral series with clinicopathological tauopathy; and (3) a pathologicall
y confirmed familial frontotemporal dementia series from Manchester, UK. Co
mparing the three clinical series: in the stringently diagnosed Manchester
frontotemporal dementia series, tau mutations were present in 13.6% of case
s (three splice-site mutations); in the clinicopathological referral series
that used more general inclusion criteria, 3 cases with P301L mutations we
re observed, which represents a lower mutation frequency of 3.6% (9.4% in f
amilial cases); in contrast, tau mutations were not detected in the Minneso
ta community-based dementia series, suggesting the occurrence of these muta
tions in dementia generally is rare (<0.2%). These data identify the preval
ence of mutations in three different clinical settings and indicate that th
is figure is sensitive to the diagnostic criteria used in each patient seri
es.